Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Madrigal Pharmaceuticals, Inc. - Common Stock
(NQ:
MDGL
)
528.52
+1.41 (+0.27%)
Streaming Delayed Price
Updated: 11:19 AM EDT, Apr 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Madrigal Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
↗
November 25, 2024
Via
The Motley Fool
3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move
↗
November 23, 2024
Via
The Motley Fool
MDGL: A Promising Play In The Weight Loss Drug Space
↗
November 22, 2024
The launch of Madrigal Pharmaceuticals Inc.’s NASH drug Rezdiffra exceeded all expectations in the recent quarterly earnings release. The stock rose more than 50% in a few days – and the company now...
Via
Talk Markets
Topics
Stocks / Equities
1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More
↗
November 10, 2024
There's a bright future ahead for this company.
Via
The Motley Fool
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
↗
November 03, 2024
Top mid-cap stock performers: MDGL (+51.70%), PRCT (+34.20%), GSAT (+33.98%), WGS (+31.17%), NXT (+25.91%), VFC (+25.82%), OMCL (+23.22%).
Via
Benzinga
Earnings Preview For Madrigal Pharmaceuticals
↗
October 30, 2024
Via
Benzinga
Earnings Scheduled For February 26, 2025
↗
February 26, 2025
Via
Benzinga
8 Health Care Stocks Whale Activity In Today's Session
↗
January 20, 2025
Via
Benzinga
Why Madrigal Pharmaceuticals Stock Was Plummeting This Week
↗
January 17, 2025
Via
The Motley Fool
Why Madrigal Pharmaceuticals Stock Is Sinking Today
↗
January 13, 2025
Via
The Motley Fool
Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
December 18, 2024
Novo Nordisk A/S is moving closer to adding more sales for its blockbuster GLP-1 drug semaglutide to treat a chronic liver disease.
Via
MarketBeat
Top 3 Health Care Stocks That May Dip This Month
↗
November 25, 2024
Via
Benzinga
Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
↗
November 01, 2024
Madrigal sells an approved MASH treatment that blasted third-quarter sales views out of the water.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 31, 2024
Via
Benzinga
Is Madrigal Pharmaceuticals Stock a Buy?
↗
August 17, 2024
The biotech could be worth a lot more in 10 years.
Via
The Motley Fool
This 1 Setback for Novo Nordisk Is Bullish for Madrigal Pharmaceuticals Stock
↗
August 14, 2024
One player's minor pain is another's moderate gain.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
↗
August 12, 2024
Via
Benzinga
Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'
↗
August 07, 2024
Acadia led a biotech selloff on Wednesday as Daybue sales missed expectations.
Via
Investor's Business Daily
Topics
Earnings
Is It Too Late to Buy Madrigal Pharmaceuticals Stock?
↗
August 05, 2024
Will being the first to its market ensure that its future is bright?
Via
The Motley Fool
7 Biotech Stocks to Keep on Your Clinical Radar
↗
July 23, 2024
Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs.
Via
InvestorPlace
Is Madrigal Pharmaceuticals a Millionaire Maker?
↗
June 30, 2024
Its revenue ramp-up is just starting, and its market looks lucrative.
Via
The Motley Fool
Is Madrigal Pharmaceuticals Stock a Buy?
↗
June 28, 2024
The company could become a prominent player in the biotech industry, but that might take a while.
Via
The Motley Fool
The Best Biotech Stock to Invest $1,000 in Right Now
↗
June 18, 2024
This stock may not be a slam dunk, but it's looking very promising.
Via
The Motley Fool
Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
↗
June 17, 2024
The company tested a GLP-1 drug in monkeys. But it might not actually be an obesity treatment.
Via
Investor's Business Daily
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
↗
June 16, 2024
Eli Lilly just drizzled on Madrigal Pharmaceuticals' parade.
Via
The Motley Fool
Where Will Madrigal Pharmaceuticals Be in 3 Years?
↗
June 15, 2024
The coast is clear for it to grow, for now.
Via
The Motley Fool
Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
↗
June 12, 2024
On Wednesday, Madrigal Pharmaceuticals stock earned an upgrade to its Relative Strength (RS) Rating, from 74 to 90.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
↗
June 11, 2024
Via
Benzinga
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
↗
June 10, 2024
Success isn't guaranteed, but both companies could become big winners.
Via
The Motley Fool
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
↗
June 05, 2024
Madrigal Pharmaceuticals and Sagimet Biosciences shares fall following Eli Lilly's presentation at the EASL Liver Congress 2024. Phase 2 tirzepatide trial shows promising results for MASH treatment....
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
